Verrica Pharmaceuticals Inc.
VRCA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001660334
In the last 90 days, Verrica Pharmaceuticals Inc. insiders filed 4 open-market purchases and 0 sales; 43 institutions reported holding it in 13F filings for Q2 2026, worth $28.5M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Verrica Pharmaceuticals Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 39 | 43 | +4 |
| Shares | 4.78M | 4.66M | −115.2K (−2.4%) |
| Value | $25.3M | $28.5M | +$3.26M (+12.9%) |
New holders (9)
Institutions that held Verrica Pharmaceuticals Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Fifth Third Bancorp | 14,000 | $85.7K | 0.00% |
| Dimensional Fund Advisors LP | 13,888 | $85.0K | 0.00% |
| XTX Topco Ltd | 13,723 | $84.0K | 0.00% |
| Two Sigma Securities, LLC | 13,045 | $79.8K | 0.01% |
| HRT Financial LP | 13,023 | $79.0K | 0.00% |
| Allied Private Wealth LLC | 202 | $1.34K | 0.00% |
| Barclays PLC | 64 | $392 | 0.00% |
| Ameritas Advisory Services, LLC | 30 | $184 | 0.00% |
| Valley National Advisers Inc | 25 | $153 | 0.00% |
Sold out (5)
Institutions that held Verrica Pharmaceuticals Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Marshall Wace, LLP | 140,497 | $743.2K |
| Stonepine Capital Management, LLC | 99,735 | $527.6K |
| Squarepoint Ops LLC | 75,208 | $397.9K |
| Optiver Holding B.V. | 31 | $164 |
| MAI Capital Management | 2 | $11 |